Leadership & Pay ·
On September 14, 2026, IR-Med, Inc. appointed Yaniv Cohen as interim Chief Executive Officer
IRMEIR-Med, Inc.
On September 14, 2026, IR-Med, Inc. appointed Yaniv Cohen as interim Chief Executive Officer. Mr. Cohen, age 46, co-founded the company's predecessor in 2013 and previously served as R&D manager and Chief Scientific Officer following the acquisition of IR-Med Ltd. He holds a Ph.D. in Informatics and Computer Engineering and an M.Sc. in Electrical Engineering, with expertise in wave propagation and IR spectroscopy for medical applications. The appointment carries no new compensatory arrangements beyond standard director programs. IR-Med, Inc. operates in the medical device industry, focusing on infrared imaging and spectral analysis technologies.